Promoter and Transcription Analysis of Penicillin-Binding Protein Genes in Streptococcus gordonii

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

An optimally cross-linked peptidoglycan requires both transglycosylation and transpeptidation, provided by class A and class B penicillin-binding proteins (PBPs). Streptococcus gordonii possesses three class A PBPs (PBPs 1A, 1B, and 2A) and two class B PBPs (PBPs 2B and 2X) that are important for penicillin resistance. High-level resistance (MIC, > or =2 microg/ml) requires mutations in class B PBPs. However, although unmutated, class A PBPs are critical to facilitate resistance development (M. Haenni and P. Moreillon, Antimicrob. Agents Chemother. 50:4053-4061, 2006). Thus, their overexpression might be important to sustain the drug. Here, we determined the promoter regions of the S. gordonii PBPs and compared them to those of other streptococci. The extended -10 box was highly conserved and complied with a sigma(A)-type promoter consensus sequence. In contrast, the -35 box was poorly conserved, leaving the possibility of differential PBP regulation. Gene expression in a penicillin-susceptible parent (MIC, 0.008 microg/ml) and a high-level-resistant mutant (MIC, 2 microg/ml) was monitored using luciferase fusions. In the absence of penicillin, all PBPs were constitutively expressed, but their expression was globally increased (1.5 to 2 times) in the resistant mutant. In the presence of penicillin, class A PBPs were specifically overexpressed both in the parent (PBP 2A) and in the resistant mutant (PBPs 1A and 2A). By increasing transglycosylation, class A PBPs could promote peptidoglycan stability when transpeptidase is inhibited by penicillin. Since penicillin-related induction of class A PBPs occurred in both susceptible and resistant cells, such a mutation-independent facilitating mechanism could be operative at each step of resistance development.

Knowledge Graph

Similar Paper

Promoter and Transcription Analysis of Penicillin-Binding Protein Genes in Streptococcus gordonii
Antimicrobial Agents and Chemotherapy 2007.0
Penicillin-Binding Protein Gene Alterations in Streptococcus uberis Isolates Presenting Decreased Susceptibility to Penicillin
Antimicrobial Agents and Chemotherapy 2010.0
An Important Site in PBP2x of Penicillin-Resistant Clinical Isolates of Streptococcus pneumoniae : Mutational Analysis of Thr338
Antimicrobial Agents and Chemotherapy 2009.0
Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility
Antimicrobial Agents and Chemotherapy 2008.0
Highly Variable Penicillin Resistance Determinants PBP 2x, PBP 2b, and PBP 1a in Isolates of Two Streptococcus pneumoniae Clonal Groups, Poland <sup>23F</sup> -16 and Poland <sup>6B</sup> -20
Antimicrobial Agents and Chemotherapy 2008.0
Diversity of Penicillin Binding Proteins among Clinical Streptococcus pneumoniae Strains from Portugal
Antimicrobial Agents and Chemotherapy 2008.0
Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to β-Lactam Antibiotics
Antimicrobial Agents and Chemotherapy 2008.0
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Antimicrobial Agents and Chemotherapy 2008.0
Overexpression of patA and patB , Which Encode ABC Transporters, Is Associated with Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2011.0
A mec A -Negative Strain of Methicillin-Resistant S taphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes
Antimicrobial Agents and Chemotherapy 2010.0